Moneycontrol
HomeNewsBusinessWipro appoints Thierry Delaporte as CEO & Managing Director
Trending Topics

Wipro appoints Thierry Delaporte as CEO & Managing Director

Abidali Neemuchwala will relinquish his position as CEO and MD on June 1.

June 01, 2020 / 14:24 IST
Story continues below Advertisement

Wipro has appointed Thierry Delaporte as Chief Operating Officer (CEO) & Managing Director  effective from July 6.

Abidali Neemuchwala will relinquish his position as CEO & MD on June 1. Rishad Premji will oversee the day to day operations of the company until July 5.

Story continues below Advertisement

Until recently, Delaporte was the COO of Capgemini Group and a member of its Group Executive Board. During his twenty-five year career with Capgemini, he held several leadership roles including that of CEO of the Global Financial Services Strategic Business Unit, and head of all global service lines.

He also oversaw Capgemini's lndia operations and led the group's transformation agenda, conceptualizing and driving several strategic programs across various business units.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show